16-Jan-2026
PRNewswire (Wed, 10-Dec 8:00 AM ET)
PRNewswire (Thu, 4-Dec 8:00 AM ET)
DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date
PRNewswire (Tue, 2-Dec 8:00 AM ET)
PRNewswire (Mon, 24-Nov 8:00 AM ET)
DarioHealth Reports Third Quarter 2025 Financial and Operating Results
PRNewswire (Thu, 13-Nov 6:30 AM ET)
PRNewswire (Wed, 12-Nov 8:30 AM ET)
DarioHealth to Report Third Quarter 2025 Results on Thursday, November 13, 2025
PRNewswire (Thu, 6-Nov 8:30 AM ET)
PRNewswire (Wed, 29-Oct 10:32 AM ET)
Market Chameleon (Thu, 25-Sep 3:34 AM ET)
Market Chameleon (Mon, 22-Sep 5:34 AM ET)
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Dariohealth Corp. trades on the NASDAQ stock market under the symbol DRIO.
As of January 16, 2026, DRIO stock price climbed to $12.44 with 3,986 million shares trading.
DRIO has a beta of 0.32, meaning it tends to be less sensitive to market movements. DRIO has a correlation of 0.00 to the broad based SPY ETF.
DRIO has a market cap of $84.07 million. This is considered a Micro Cap stock.
Last quarter Dariohealth Corp. reported $5 million in Revenue and -$1.91 earnings per share. This fell short of revenue expectation by $-680,000 and exceeded earnings estimates by $1.12.
In the last 3 years, DRIO traded as high as $135.60 and as low as $5.94.
The top ETF exchange traded funds that DRIO belongs to (by Net Assets): VXF, DFAS.
DRIO has underperformed the market in the last year with a return of -4.3%, while the SPY ETF gained +18.1%. In the last 3 month period, DRIO fell short of the market, returning -4.6%, while SPY returned +5.0%. However, in the most recent 2 weeks DRIO has outperformed the stock market by returning +18.3%, while SPY returned +1.2%.
DRIO support price is $11.28 and resistance is $13.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DRIO shares will trade within this expected range on the day.